The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Karydas Daphne since 2025.
This trader's CIK number is 1816952.
At the time of last reporting, Karydas Daphne was the Director of Mineralys Therapeutics, Inc.. (stock ticker symbol MLYS).
Also see all insider trading activities at Mineralys Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MLYS | 0 | $0 | 15,000 | $691,230 | 15,000 | $153,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-13 | MLYS | Option Ex | 15,000 | 10.20 | 153,000 |
| 2025-11-13 | MLYS | Sale | 15,000 | 46.08 | 691,230 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Karydas Daphne (Director of Mineralys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.